GlaxoSmithKline, LLC. recalls Sumatriptan Succinate Injection, 6 mg, 0.5 mL For subcutaneous injection only, Rx only, 2 Single-Dose Syringe Cartridges
Recalled January 1, 2014 · FDA recall D-388-2014 · GlaxoSmithKline
Hazard
Lack of Assurance of Sterility: A small number of pre-filled syringes may contain needles which protrude through the needle shield. · FDA Class II
Units
9,743 cartridges
Sold at
Nationwide
Description
Lack of Assurance of Sterility: A small number of pre-filled syringes may contain needles which protrude through the needle shield.
Product
Sumatriptan Succinate Injection, 6 mg, 0.5 mL For subcutaneous injection only, Rx only, 2 Single-Dose Syringe Cartridges for use with sumatriptan Autoinjector Pen, Manufactured by GlaxoSmithKline, Research Triangle Park, NC 27709 for Sandoz Inc., Princeton, NJ 08540, Made in Singapore, NDC 0781-3173-07.
Manufacturer(s)
GlaxoSmithKline, LLC.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →